RxGen HelixRxGen is a specialty translational research company focused exclusively on the development and application of in vivo disease models to accelerate the evaluation, selection, and development of candidate therapeutics and drug delivery technologies.

RxGen offers a wide range of preclinical research models and related services, with a specific focus on central nervous system (CNS), ophthalmic and metabolic disorders.

Latest RxGen News